학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 146건 | 목록
1~20
Academic Journal
Chen, S; Venkatesan, S; Arnetorp, S; Bergenheim, K; Dube, S; Meeraus, W; Ferreira, C; Taylor, S; White, LJ
PLoS Comput Biol
PLoS Computational Biology, Vol 21, Iss 6 (2025)
PLoS Computational Biology, Vol 21, Iss 6 (2025)
Academic Journal
Aurer I; University Hospital Centre Zagreb, 10000 Zagreb, Croatia.; Department of Internal Medicine, Medical School, University of Zagreb, 10000 Zagreb, Croatia.; Moss P; College of Medicine and Health, University of Birmingham, Birmingham, B15 2TT, UK.; University Hospitals Birmingham, NHS Foundation Trust, Birmingham, B15 2GW, UK.; Goldman M; I3h Institute, Université Libre de Bruxelles, Bruxelles 1050, Belgium.; Tuthill M; University of Oxford, Manor Hospital/Genesis Care, Oxford, OX4 6LB, UK.; Einsele H; Department of Internal Medicine II, Würzburg University Hospital, Würzburg 97080, Germany.; Casañas I Comabella C; EVIDERA, Evidence, Value and Access by PPD, Granta Park Great Abington, Cambridge, CB21 6GQ, UK.; James S; EVIDERA, Evidence, Value and Access by PPD, Paris, 94853, France.; Borkowska K; EVIDERA, Evidence, Value and Access by PPD, Warsaw, 02-672, Poland.; Jah F; Medical Affairs, BioPharmaceuticals Medical, AstraZeneca, Hamburg, 22763, Germany.; Dube S; Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, CB2 0AA, UK.; Klein S; Medical Affairs, BioPharmaceuticals Medical, AstraZeneca, Groot-Bijgaarden, 1702, Belgium.; Kandeil W; Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Baar, 6340, Switzerland.; Yokota R; P95 Epidemiology & Pharmacovigilance, Leuven, 3000, Belgium.; Pagliuca A; Stem Cell Transplantation, King's College London/King's College Hospital, London, SE5 9RS, UK.; Magiorkinis G; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian, University of Athens, Athens 115 72, Greece.; Arnetorp S; Health Economics & Payer Evidence, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, 431 50, Sweden.; Lee L; Centre for Immuno-oncology, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Spinner CD; TUM School of Medicine and Health, Department of Clinical Medicine, Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich, 81675, Munich, Germany. christoph.spinner@mri.tum.de.; Bell S; Division of Population Health and Genomics, University of Dundee, Ninewells Hospital, Dundee, Scotland.; Einsele H; Department of Internal Medicine II, University Hospital Würzburg, 97080, Würzburg, Germany.; Tremblay C; Research Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0C1, Canada.; Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Goldman M; Université Libre de Bruxelles, Brussels, Belgium.; Chagla Z; McMaster University, Hamilton, ON, Canada.; Finckh A; University of Geneva, Geneva, Switzerland.; Edwards CJ; NIHR Southampton Clinical Research Facility, University Hospital Southampton, NHS Foundation Trust, Southampton Hampshire, UK.; Aurer I; University Hospital Center Zagreb Kišpatićeva ul. 12, and Medical School, University of Zagreb, Šalata 3, 10000, Zagreb, Croatia.; Launay O; Université Paris Cité; Inserm CIC1417, F-CRIN I REIVAC; Assistance, Publique Hôpitaux de Paris, Cochin Hospital, Paris, France.; Casañas I Comabella C; Evidera, Evidence, Value and Access by PPD, Granta Park Great Abington, Cambridge, UK.; James S; Evidera, Evidence, Value and Access by PPD, Paris, France.; Dube S; Epidemiology, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK.; Borkowska K; Evidera, Evidence, Value and Access by PPD, Granta Park Great Abington, Cambridge, UK.; Jah F; Medical Affairs, BioPharmaceuticals Medical, AstraZeneca, Hamburg, Germany.; Kandeil W; Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Baar, Switzerland.; Yokota RTC; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium.; Artaud C; Medical Affairs, Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Courbevoie, France.; Gottenberg JE; Strasbourg University Hospital, Université de Strasbourg, 67000, Strasbourg, France.; Gesualdo L; Renal, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.; Bertrand D; Department of Nephrology and Transplantation, University of Rouen, Rouen, France.; Arnetorp S; Health Economics & Payer Evidence, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.; Magiorkinis G; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 115 72, Athens, Greece.
Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Dube, S; Lu, Y; McNulty, R; Graham, S; Arnetorp, S; Justo, N; Yokota, R; Evans, K; Venkatesan, S; Yates, M
OPEN FORUM INFECTIOUS DISEASES. 10(Supplement_2)
Dube, S; Lu, Y; McNulty, R; Graham, S; Arnetorp, S; Justo, N; Yokota, R; Evans, K; Venkatesan, S; Yates, M
OPEN FORUM INFECTIOUS DISEASES. 10(Supplement_2)
McNulty, R; Dube, S; Lu, Y; Graham, S; Arnetorp, S; Justo, N; Yokota, R; Evans, K; Venkatesan, S; Yates, M
OPEN FORUM INFECTIOUS DISEASES. 10(Supplement_2)
Academic Journal
Maia T; Patient Centered Solutions, IQVIA, 2740-266 Porto Salvo, Portugal.; Yokota R; Epidemiology & Pharmacovigilance, P95, 3001 Leuven, Belgium.; Arnetorp S; Health Economics & Payer Evidence, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, 431 83 Gothenburg, Sweden.; Smith J; Patient representative, Vale of Glamorgan, UK.; Rae-Garwood G; Patient representative, Glendale, AZ, USA.; Settergren G; Global Evidence Portfolio Delivery, BioPharmaceuticals Medical, AstraZeneca, 431 83 Gothenburg, Sweden.; Eckerd M; Global Patient Engagement R&I, AstraZeneca, Wilmington, DE 19850, USA.; Williams P; Patient Centered Solutions, IQVIA, 92400 Courbevoie, France.; Patient Centered Science, Vaccine & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, 431 83 Gothenburg, Sweden.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE
Academic Journal
Sjöholm, Kajsa; Peltonen, Markku; Jacobson, Peter; Andersson-Assarsson, Johanna C; Ahlin, Sofie; Adméus, Lucas; Arnetorp, Ida; Engström, My; Taube, Magdalena; Carlsson, Lena M S; Svensson, Per-Arne
British Journal of Surgery; Oct2025, Vol. 112 Issue 10, p1-9, 9p
Academic Journal
Value in Health. 26(12):S55-S55
Academic Journal
Advances in Therapy. 37:4190-4208
Academic Journal
Lloyd, A.; Arnetorp, S.; Marcus, J.; Yokota, R.T.C.; Herring, T.A.; Powell, P.A.; Rohay, J.; Severens, J.L.; Venkatesan, S.; Williams, P.; Maia, T.; Taylor, S.; Krol, M.; Ware, J.E., Jr.
Value in Health. 26(12):S492-S492
Academic Journal
Powell, P.A.; Williams, P.; Herring, T.A.; Venkatesan, S.; Arnetorp, S.; Lloyd, A.; Marcus, J.; Ouwens, M.; Rohay, J.; Severens, J.L.; Yokota, R.T.C.; Maia, T.; Taylor, S.; Krol, M.; Ware, J.E., Jr.
Value in Health. 26(12):S482-S482
Academic Journal
Powell, P.; Maia, T.; Arnetorp, S.; Yokota, R.T.C.; Herring, T.A.; Lloyd, A.; Marcus, J.; Severens, J.; Venkatesan, S.; Eckerd, M.; Taylor, S.; Williams, P.; Ware, J.E., Jr.
Value in Health. 26(12):S482-S482
Academic Journal
Powell, P.; Marcus, J.; Venkatesan, S.; Williams, P.; Arnetorp, S.; Herring, T.A.; Lloyd, A.; Severens, J.L.; Varni, J.; Yokota, R.T.C.; Maia, T.; Taylor, S.; Krol, M.; Ware, J.E., Jr.
Value in Health. 26(12):S471-S471
Academic Journal
Value in Health. 26(12):S377-S377
Academic Journal
Value in Health. 26(6):S81-S82
Academic Journal
Williams P; Global Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.; Patient Centered Solutions, IQVIA, Courbevoie, France.; Herring TA; Medical Evidence, Epidemiology, Vaccine & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, United States.; Yokota RTC; P95, Epidemiology & Pharmacovigilance, Leuven, Belgium.; Maia T; Patient Centered Solutions, IQVIA, Porto Salvo, Portugal.; Venkatesan S; BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.; Marcus JC; Patient Centered Solutions, IQVIA, Washington, DC, United States.; Settergren G; Global Evidence Portfolio Delivery, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.; Arnetorp S; Health Economic & Payer Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.; Lloyd A; Acaster Lloyd Consulting Ltd, London, United Kingdom.; Severens JL; Severens HTA Consultancy, Venray, Netherlands.; Varni JW; Texas A&M University, College Station, TX, United States.; Dixon S; Patient representative, Sulphur Springs, TX, United States.; Hamusankwa L; Patient representative, London, United Kingdom.; Powell PA; Sheffield Centre for Health and Related Research (SCHARR), University of Sheffield, Sheffield, United Kingdom.; Philip A Powell Consulting, Sheffield, United Kingdom.; Taylor S; Medical Evidence, Vaccine & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.; Ware JE Jr; John Ware Research Group, Watertown, ME, United States.; Krol M; Patient Centered Solutions, IQVIA, Amsterdam, Netherlands.
Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Internet ISSN: 1929-0748 (Electronic) Linking ISSN: 19290748 NLM ISO Abbreviation: JMIR Res Protoc Subsets: MEDLINE
Academic Journal
Value in Health. 26(6):S322-S322
Academic Journal
Bell, E; Brassel, S; Schirrmacher, H; Oliver, E; Arnetorp, S; Berg, K; Darroch-Thompson, D; Pohja-Hutchison, P; Mungall, B; Carroll, S; Postma, MJ; Steuten, L
Value in Health. 25(12):S244-S244
검색 결과 제한하기
제한된 항목
[검색어] Arnetorp, S
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어